Real-time detection and visualization of amyloid-β aggregates induced by hydrogen peroxide in cell and mouse models of Alzheimer's disease

X Wang, A Iyaswamy, D Xu… - … Applied Materials & …, 2022 - ACS Publications
Oxidative stress, caused by an imbalance between the production and the accumulation of
reactive oxygen species (ROS), is a prominent cause of the neurotoxicity induced by …

Application of biomarker-derived fluorescent probes for the detection of Alzheimer's disease

H Ding, Z Li, K Luo, Q Gong, X Tian - TrAC Trends in Analytical Chemistry, 2023 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the
accumulation of beta-amyloid (Aβ) protein and neurofibrillary tangles in the brain, resulting …

Preclinical models for Alzheimer's disease: past, present, and future approaches

A Akhtar, SM Gupta, S Dwivedi, D Kumar… - ACS …, 2022 - ACS Publications
A robust preclinical disease model is a primary requirement to understand the underlying
mechanisms, signaling pathways, and drug screening for human diseases. Although various …

[HTML][HTML] Small-molecule theranostics in Alzheimer's disease

Á Sarabia-Vallejo, P López-Alvarado… - European Journal of …, 2023 - Elsevier
Alzheimer's Disease (AD) remains one of the most challenging health-related issues for our
society. It is becoming increasingly prevalent, especially in developed countries, due to the …

Isoliquiritigenin mitigates oxidative damage after subarachnoid hemorrhage in vivo and in vitro by regulating Nrf2-dependent Signaling Pathway via Targeting of …

JQ Liu, XT Zhao, FY Qin, JW Zhou, F Ding, G Zhou… - Phytomedicine, 2022 - Elsevier
Background Oxidative stress is a crucial factor leading to subarachnoid hemorrhage (SAH)-
induced early brain injury (EBI). Isoliquiritigenin has been verified as a powerful anti-oxidant …

Pyrazoline containing compounds as therapeutic targets for neurodegenerative disorders

MJ Ahsan, A Ali, A Ali, A Thiriveedhi, MA Bakht… - ACS …, 2022 - ACS Publications
Pyrazolines are a significant class of heterocyclic compounds with essential biological
activities. They are quite stable, which has inspired medicinal chemists to experiment with …

Bromo-protopine, a novel protopine derivative, alleviates tau pathology by activating chaperone-mediated autophagy for Alzheimer's disease therapy

SG Sreenivasmurthy, A Iyaswamy… - Frontiers in Molecular …, 2022 - frontiersin.org
Emerging evidence from Alzheimer's disease (AD) patients suggests that reducing tau
pathology can restore cognitive and memory loss. To reduce tau pathology, it is critical to …

Small molecular fluorescent probes for Alzheimer's disease associated active species

F Tang, K Wang, X Liu, X Zhang, W Zhou… - … A European Journal, 2023 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and is the main
cause of dementia worldwide. As the pathogenesis of AD is quite complicated, there is …

Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer's Disease

NG Bajad, A Kumar, SK Singh - ACS Chemical Neuroscience, 2023 - ACS Publications
The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical regions of the
brain of Alzheimer's disease (AD) patients is considered the foremost pathological hallmark …

[HTML][HTML] TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications

Z Gu, H Cao, C Zuo, Y Huang, J Miao, Y Song… - Neurobiology of …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), an age-dependent neurodegenerative disorder, is the
most prevalent neurodegenerative disease worldwide. The primary pathological hallmarks …